Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
暂无分享,去创建一个
A. Zauber | N. Nishioka | M. Bertagnolli | E. Hawk | M. Redston | C. Gostout | J. Hornick | F. Giardiello | J. Saltzman | S. Sontag | A. Carothers | N. Cho | C. Eagle | A. Wilton
[1] R. Stevens,et al. Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. , 2007, Cancer letters.
[2] J. Jass. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.
[3] M. Mäkinen,et al. Colorectal serrated adenocarcinoma , 2007, Histopathology.
[4] S. Solomon,et al. Celecoxib for the prevention of sporadic colorectal adenomas. , 2006, The New England journal of medicine.
[5] S. Solomon,et al. Celecoxib for the prevention of colorectal adenomatous polyps. , 2006, The New England journal of medicine.
[6] D. Anagnostakis,et al. Expression of Smad4 and TGF-β2 in Colorectal Carcinoma , 2006 .
[7] M. Bertagnolli,et al. Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor. , 2006, Cancer research.
[8] R. Fodde,et al. Smad4 haploinsufficiency in mouse models for intestinal cancer , 2006, Oncogene.
[9] J. Jass,et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer , 2006, Histopathology.
[10] S. Cross,et al. Role of aberrant crypt foci detected using high‐magnification‐chromoscopic colonoscopy in human colorectal carcinogenesis , 2005, Journal of gastroenterology and hepatology.
[11] V. Steele,et al. Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors. , 2004, Carcinogenesis.
[12] P. Adegboyega,et al. Subepithelial Myofibroblasts Express Cyclooxygenase-2 in Colorectal Tubular Adenomas , 2004, Clinical Cancer Research.
[13] M. Byrne,et al. The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas , 2004, European journal of gastroenterology & hepatology.
[14] A. Nissan,et al. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer , 2003, Gut.
[15] G. Beck,et al. A randomized trial of aspirin to prevent colorectal adenomas. , 2003, The New England journal of medicine.
[16] Christopher J Gostout,et al. Endoscopic identification and quantification of aberrant crypt foci in the human colon. , 2002, Gastrointestinal endoscopy.
[17] J. Masferrer. Approach to angiogenesis inhibition based on cyclooxygenase-2. , 2001, Cancer journal.
[18] B. Levin,et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.
[19] V. Steele,et al. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. , 2000, Carcinogenesis.
[20] Junji Kato,et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer , 1998, The New England journal of medicine.
[21] H. Esumi,et al. Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue , 1998, Cancer.
[22] L. Roncucci,et al. K‐ras AND p53 MUTATIONS IN HUMAN COLORECTAL ABERRANT CRYPT FOCI , 1996, The Journal of pathology.
[23] H. Esumi,et al. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. , 1995, Gastroenterology.
[24] K. Kinzler,et al. Molecular determinants of dysplasia in colorectal lesions. , 1994, Cancer research.
[25] M. Ghia,et al. Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. , 1994, Cancer letters.
[26] A. Zauber,et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .
[27] R. Bird,et al. Aberrant crypts: potential preneoplastic lesions in the murine colon. , 1988, Cancer research.
[28] R P Bird,et al. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.
[29] Steven Gallinger,et al. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. , 2007, Cancer research.
[30] P. Laird,et al. DNA methylation profiles of female steroid hormone-driven human malignancies. , 2006, Current topics in microbiology and immunology.
[31] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.